NovaSignal's AI-Guided Robotic Platform Aims To Change The Diagnosis Of Stroke

NovaSignal's AI-driven automated cerebral doppler ultrasound system. Los Angeles based NovaSignal Inc. recently launched a second version of their artificial intelligence (AI)-guided robotic platform for assessing cerebral blood flow in order to guide real-time diagnosis. The platform uses ultrasound to autonomously capture blood flow data, which then gets sent to their HIPAA-compliant cloud system so that clinicians can access the exam data from anywhere on their personal devices. Founded in 2013, the company states they have raised over $25 million in federal research funding and hold 18 patents. They also have over 130 peer-reviewed citations to their work.